Defective mismatch repair in colon cancer: A prognostic or predictive biomarker?

Journal of Clinical Oncology

Volumn 28, Issue 20, 2010, Pages 3210-3212

  Kerr, David J ^a,b   Midgley, Rachel ^b  

^a SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FLUOROURACIL; FOLINIC ACID; K RAS PROTEIN; MISMATCH REPAIR PROTEIN; OXALIPLATIN; ANTINEOPLASTIC ANTIMETABOLITE; BIOLOGICAL MARKER;

CANCER ADJUVANT THERAPY; CANCER RESISTANCE; COLON CANCER; COLORECTAL CANCER; DISEASE FREE SURVIVAL; EDITORIAL; GENE MUTATION; GENETIC MODEL; HUMAN; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; OBSERVATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; ADJUVANT CHEMOTHERAPY; COLON TUMOR; GENETICS; NOTE;

ANTIMETABOLITES, ANTINEOPLASTIC; BIOLOGICAL MARKERS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DNA MISMATCH REPAIR; FLUOROURACIL; HUMANS; PROGNOSIS;

EID: 77954724833     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.28.9322     Document Type: Editorial

References (16)

1. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis Cell 61:759-767, 1990
2. Walther A, Johnstone E, Swanton C, et al: Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 9:489-499, 2009
3. Russo A, Bazan V, Iacopetta B, et al: The TP53 Colorectal Cancer International Collaborative Study on the Prognostic and Predictive Significance of p53 Mutation: Influence of tumour site, type of mutation, and adjuvant treatment. J Clin Oncol 23:7518-7528, 2005 (Pubitemid 46291815)
4. Popat S, Matakidou A, Houlston RS: Thymidylate synthase expression and prognosis in colorectal cancer: A systematic review and meta-analysis. J Clin Oncol 22:529-536, 2004 (Pubitemid 41079782)
5. Ogino S, Nosho K, Irahara N, et al: Prognostic significance and molecular associations of 18q loss of heterozygosity: A cohort study of microsatellite stable colorectal cancers. J Clin Oncol 27:4591-4598, 2009
6. Thibodeau SN, Bren G, Schaid D: Microsatellite instability in cancer of the proximal colon. Science 260:816-819, 1993 (Pubitemid 23167612)
7. Lindor NM, Burgart LJ, Leontovich O, et al: Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 20:1043-1048, 2002 (Pubitemid 34141849)
8. Lanza G, Gafà R, Santini A, et al: Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. J Clin Oncol 24:2359-2367, 2006 (Pubitemid 46630668)
9. Kakar S, Aksoy S, Burgart LJ, et al: Mucinous carcinoma of the colon: Correlation of loss of mismatch repair enzymes with clinicopathologic features and survival. Mod Pathol 17:696-700, 2004 (Pubitemid 38715493)
10. Popat S, Hubner R, Houlston RS: Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23:609-618, 2005 (Pubitemid 46224239)
11. Elsaleh H, Joseph D, Grieu F, et al: Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 355: 1745-1750, 2000 (Pubitemid 30265078)
12. Sargent D, Marsoni S, Monges G, et al: Defective mismatch repair as a predictive marker for lack of efficacy of FU-based adjuvant therapy in colon cancer. J Clin Oncol 28:3219-3227, 2010
13. Ribic CM, Sargent DJ, Moore MJ, et al: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349:247-257, 2003 (Pubitemid 36859476)
14. QUASAR Collaborative Group, Gray R, Barnwell J, et al: Adjuvant chemotherapy versus observation in patients with colorectal cancer: A randomised study. Lancet 370:2020-2029, 2007 (Pubitemid 350236339)
15. Roth AD, Tejpar S, Yan P, et al: Correlation of molecular markers in colon cancer with stage-specific prognosis: Results of the translational study on the PETACC3 - EORTC 40993-SAKK 60-00 trial. Presented at the ASCO GI Cancer Symposium, San Francisco, CA, January 15-17, 2009 (abstr 288)
16. Kerr D, Gray R, Quirke P, et al: A quantitative multigene RT-PCR assay for prediction of recurrence in stage II colon cancer: Selection of the genes in four large studies and results of the independent, prospectively designed QUASAR validation study. J Clin Oncol 27:15s, 2009 (suppl; abstr 4000)